• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    New Research Illustrates Gaps in COPD Care and the Need for Better Patient-Provider Communication

    7/30/25 4:05:00 PM ET
    $PHR
    Real Estate
    Real Estate
    Get the next $PHR alert in real time by email

    Patients with chronic obstructive pulmonary disease (COPD) face significant challenges, but conversations with healthcare providers can play a critical role in helping patients understand their condition, set realistic goals, ease symptom burden and improve their quality of life, according to new research from the COPD Foundation and Phreesia.

    COPD is a chronic and progressive lung disease that affects more than 16 million people in the United States and is the sixth leading cause of death.

    The study, published in Chronic Obstructive Pulmonary Diseases: The Journal of the COPD Foundation, with funding support from Verona Pharma, was based on voluntary surveys from 1,615 COPD patients in January 2025. Patients completed the survey on Phreesia's platform after checking in for their doctor appointments and providing consent.

    Patients reported significant symptom burden, with 43% of patients saying they experience COPD symptoms, including shortness of breath and fatigue, at least 24 days in a typical month and a quarter of patients reporting symptoms every day. Patients also reported significant impacts to their quality of life, with around two-thirds saying COPD had a moderate-to-great impact on their daily lives and half reporting a moderate-to-great impact on their emotional health. COPD also impacted patients' ability to work, with 15% saying they had lost a job due to their condition.

    Surveyed patients also reported barriers to medication. One in five patients reported not using any maintenance medications. Among those patients, 27% said they didn't think their COPD was severe enough and 27% said their provider had not recommended maintenance therapy. Seventy-one percent of patients who had not tried any COPD medications said they would be likely to try them. And among patients who had tried maintenance medications, 80% said it was because their doctor had recommended it.

    Despite this opportunity for patient-provider discussions around maintenance medications and other treatment options, the study found significant communication gaps between patients and their healthcare providers. Only 45% of patients reported having detailed discussions about their COPD symptoms with their providers, and 22% of patients said they provided little to no symptom detail during visits. Additionally, more than a third of patients reported having limited to no understanding of COPD. That percentage was even higher among Black patients and patients aged 45−64 years, 46% and 41% respectively, highlighting the potential for targeted interventions.

    "These findings point to the urgent need to improve communication between patients and their providers and ensure conversations are as engaging, informative and productive as possible," said David Mannino, MD, Co-Founder and Medical Director of the COPD Foundation and the study's lead author. "Equipping patients with the right information and resources can help them take a more active role in their care and improve health outcomes."

    "Given what we know about the benefits of giving patients relevant, credible health information at the point of care, these results have important implications that can be used to support patients struggling with COPD," said David Linetsky, Phreesia's President, Network Solutions. "At Phreesia, we've seen firsthand that when patients have more meaningful conversations with their providers, it helps them manage their treatment and improves quality of life."

    For more information on Phreesia, visit www.phreesia.com.

    About Phreesia

    Phreesia is the trusted leader in patient activation, giving healthcare providers, life sciences companies and other organizations tools to help patients take a more active role in their care. Founded in 2005, Phreesia enabled approximately 170 million patient visits in 2024—1 in 7 visits across the U.S.—scale that we believe allows us to make meaningful impact. Offering patient-driven digital solutions for intake, outreach, education and more, Phreesia enhances the patient experience, drives efficiency and improves healthcare outcomes. To learn more, visit phreesia.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250730220894/en/

    Media Contact:

    Maureen McKinney

    [email protected]

    773-330-8908

    Get the next $PHR alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PHR

    DatePrice TargetRatingAnalyst
    8/27/2025$36.00Outperform
    Mizuho
    1/8/2025$24.00 → $32.00Sector Perform → Outperform
    RBC Capital Mkts
    2/26/2024$35.00Buy
    Truist
    1/17/2024$30.00 → $32.00Neutral → Buy
    DA Davidson
    1/3/2024$29.00Overweight
    Barclays
    4/12/2023$37.00Overweight
    Stephens
    1/4/2023$35.00 → $40.00Buy
    Needham
    12/13/2022$40.00Neutral → Buy
    Citigroup
    More analyst ratings

    $PHR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Mizuho initiated coverage on Phreesia with a new price target

    Mizuho initiated coverage of Phreesia with a rating of Outperform and set a new price target of $36.00

    8/27/25 8:26:07 AM ET
    $PHR
    Real Estate

    Phreesia upgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts upgraded Phreesia from Sector Perform to Outperform and set a new price target of $32.00 from $24.00 previously

    1/8/25 8:20:24 AM ET
    $PHR
    Real Estate

    Truist initiated coverage on Phreesia with a new price target

    Truist initiated coverage of Phreesia with a rating of Buy and set a new price target of $35.00

    2/26/24 8:19:13 AM ET
    $PHR
    Real Estate

    $PHR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Phreesia Announces Second Quarter Fiscal 2026 Results

    Phreesia, Inc. (NYSE:PHR) ("Phreesia" or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2025. "I am proud to share that Phreesia has had many noteworthy developments over the past quarter. In addition to delivering another solid set of financial results, including achieving our first-ever net income positive quarter, we have expanded our reach and capabilities, positioning us well for the future. I am also excited to share that we entered into a definitive agreement to acquire AccessOne, a market leader in providing financing solutions for healthcare receivables. Please refer to the AccessOne press release published earlier today for addition

    9/4/25 4:05:00 PM ET
    $PHR
    Real Estate

    Phreesia to Acquire AccessOne, Expanding Its Suite of Payment Solutions

    Phreesia, Inc. (NYSE:PHR) ("Phreesia"), a trusted leader in patient activation, today announced it has entered into a definitive agreement to acquire AccessOne Parent Holdings, Inc. (together with its subsidiaries, "AccessOne"), a portfolio company of Frontier Growth, for aggregate consideration of $160 million in cash (the "AccessOne Acquisition"). The transaction is expected to close during the third quarter or early fourth quarter of Phreesia's 2026 fiscal year, subject to customary closing conditions and regulatory approvals. AccessOne is a market leader in providing financing solutions for healthcare receivables, working with some of the largest health systems in the U.S. AccessOne t

    9/4/25 4:03:00 PM ET
    $PHR
    Real Estate

    Phreesia Launches VoiceAI, a Conversational AI Solution to Transform Call Management in Healthcare

    New offering enhances Phreesia's existing platform, eliminating long hold times and ensuring every patient call is resolved Phreesia, a leader in patient activation, today announced the launch of Phreesia VoiceAI, an always-on, intelligent AI phone solution purpose-built for healthcare. VoiceAI leverages advanced natural language processing and real-time workflow integration to help healthcare organizations manage high call volumes, streamline routine interactions and improve the patient experience—all without increasing staff workload. VoiceAI allows patients to easily resolve common requests by using patients' natural spoken language. VoiceAI then triages and routes those patient requ

    9/2/25 4:04:00 PM ET
    $PHR
    Real Estate

    $PHR
    SEC Filings

    View All

    Phreesia Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Phreesia, Inc. (0001412408) (Filer)

    9/4/25 4:06:24 PM ET
    $PHR
    Real Estate

    SEC Form 144 filed by Phreesia Inc.

    144 - Phreesia, Inc. (0001412408) (Subject)

    8/22/25 4:54:46 PM ET
    $PHR
    Real Estate

    SEC Form 144 filed by Phreesia Inc.

    144 - Phreesia, Inc. (0001412408) (Subject)

    8/18/25 3:19:54 PM ET
    $PHR
    Real Estate

    $PHR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Indig Chaim sold $3,204,912 worth of shares (99,993 units at $32.05) and exercised 99,993 shares at a strike of $7.24, increasing direct ownership by 0.15% to 1,253,236 units (SEC Form 4)

    4 - Phreesia, Inc. (0001412408) (Issuer)

    8/29/25 4:12:39 PM ET
    $PHR
    Real Estate

    President, Provider Solutions Roberts Evan sold $1,555,972 worth of shares (48,547 units at $32.05), decreasing direct ownership by 6% to 724,368 units (SEC Form 4)

    4 - Phreesia, Inc. (0001412408) (Issuer)

    8/29/25 4:11:10 PM ET
    $PHR
    Real Estate

    Chief Financial Officer Gandhi Balaji sold $287,550 worth of shares (9,583 units at $30.01), decreasing direct ownership by 9% to 97,078 units (SEC Form 4)

    4 - Phreesia, Inc. (0001412408) (Issuer)

    8/27/25 4:16:28 PM ET
    $PHR
    Real Estate

    $PHR
    Leadership Updates

    Live Leadership Updates

    View All

    Phreesia Joins the Network Advertising Initiative as a Member, Demonstrating Ongoing Commitment to Industry-Leading Privacy Practices

    Phreesia will work with the NAI to shape the national conversation around data privacy and promote consumer choice and transparency As part of the company's ongoing commitment to consumer data privacy, Phreesia is pleased to announce it has joined the Network Advertising Initiative (NAI), a non–profit organization and the leading self-regulatory association dedicated to responsible data collection and use for digital advertising. As a member, Phreesia will work with the NAI to promote consumer-centric privacy practices in healthcare and take a leadership role in shaping the national conversation around data privacy. "We are excited to join the NAI, an organization that shares our dedicati

    10/8/24 6:48:00 AM ET
    $PHR
    Real Estate

    Phreesia's Audrey Gato Named as a Top Woman Leader in SaaS

    Phreesia, a leader in patient intake, outreach and activation, is proud to announce that Audrey Gato, Vice President of Client Solutions, has been named to The Software Report's list of the Top 50 Women Leaders in SaaS of 2023. Honorees were chosen based on their leadership and contributions to the Software-as-a-Service industry. This is the sixth consecutive year a female leader from Phreesia has been named to the list. Previous Phreesia awardees include Allison Hoffman, General Counsel; Kristin Roberts, Vice President of Product Management; Kharen Hauck, Vice President of Marketing; Amy VanDuyn, Senior Vice President of Human Resources; and Sara DiNardo, Vice President of Client Solutio

    1/16/24 4:05:00 PM ET
    $PHR
    Real Estate

    $PHR
    Financials

    Live finance-specific insights

    View All

    Phreesia Announces Second Quarter Fiscal 2026 Results

    Phreesia, Inc. (NYSE:PHR) ("Phreesia" or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2025. "I am proud to share that Phreesia has had many noteworthy developments over the past quarter. In addition to delivering another solid set of financial results, including achieving our first-ever net income positive quarter, we have expanded our reach and capabilities, positioning us well for the future. I am also excited to share that we entered into a definitive agreement to acquire AccessOne, a market leader in providing financing solutions for healthcare receivables. Please refer to the AccessOne press release published earlier today for addition

    9/4/25 4:05:00 PM ET
    $PHR
    Real Estate

    Phreesia Sets Release Date for Fiscal Second Quarter 2026 Results

    Phreesia, Inc. (NYSE:PHR) ("Phreesia") today announced that it will release its fiscal second quarter 2026 financial results after the close of market trading on Thursday, Sept. 4, 2025. Phreesia will issue a press release announcing its quarterly results and the company's quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal second quarter results starting at 5PM Eastern Time on the same day. To participate in the company's live conference call and webcast, please dial (800) 715-9871, or (646) 307-1963 for international participants, using conference code number 7404611, or vi

    8/7/25 4:05:00 PM ET
    $PHR
    Real Estate

    Phreesia Announces First Quarter Fiscal 2026 Results

    Phreesia, Inc. (NYSE:PHR) ("Phreesia" or the "Company") announced financial results today for the fiscal first quarter ended April 30, 2025. "Our fiscal year 2026 is off to a strong start. I am grateful to our team for their continued commitment to our mission, vision and values. I believe our performance is a reflection of our team truly living our values," said CEO and Co-Founder Chaim Indig. Please visit the Phreesia investor relations website at ir.phreesia.com to view the Company's Q1 Fiscal 2026 Stakeholder Letter. Fiscal First Quarter Ended April 30, 2025 Highlights Total revenue was $115.9 million in the quarter, up 15% year-over-year. Average number of healthcare servi

    5/28/25 7:03:00 AM ET
    $PHR
    Real Estate

    $PHR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Phreesia Inc.

    SC 13G/A - Phreesia, Inc. (0001412408) (Subject)

    11/12/24 10:34:15 AM ET
    $PHR
    Real Estate

    Amendment: SEC Form SC 13G/A filed by Phreesia Inc.

    SC 13G/A - Phreesia, Inc. (0001412408) (Subject)

    7/8/24 4:37:20 PM ET
    $PHR
    Real Estate

    SEC Form SC 13G/A filed by Phreesia Inc. (Amendment)

    SC 13G/A - Phreesia, Inc. (0001412408) (Subject)

    2/16/24 4:57:01 PM ET
    $PHR
    Real Estate